A Comparison of the Bronchodilating Activity of Symbicort pMDI 160/4.5 Used in the Conventional Manner and With a Valved Spacer Holding Chamber (Aerochamber Plus)
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 Mar 2010 Results have been presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) held in the USA in Feb-Mar 2010.
- 02 Mar 2010 Status changed from active, no longer recruiting to completed.
- 18 Jun 2009 New trial record